HOME  |  CONTACT  |  SITEMAP   
Home > 연구지원 > Research Directory

| Research Directory


저자명 구분 논문제목 ISSN IF 발행일자
송진우 SCIE Sarcoid-like reaction in patients with malignant tumors: Long-term clinical course and outcomes 2296-858X 2022-08-17
이상민 SCIE Characteristics and outcomes of anterior mediastinal cystic lesions diagnosed on chest MRI: implications for management of cystic lesions 1869-4101 2022-08-17
이창환 SCIE Lamin-A/C Is Modulated by the Involvement of Histamine-Mediated Calcium/Calmodulin-Dependent Kinase II in Lung Cancer Cells 1422-0067 2.598 2022-08-13
정석훈 SSCI Applicability and Psychometric Comparison of the General-Population Viral Anxiety Rating Scales among Healthcare Workers in the COVID-19 Pandemic 1660-4601 2022-08-12
이필형 SCIE Incidence and predictors of intracranial bleeding after coronary artery bypass graft surgery 2297-055X 5.848 2022-08-12
심태선 SCIE Treatment outcomes of multidrug-resistant tuberculosis with chronic kidney/liver disease 0903-1936 5.895 2022-08-10
정석훈 SCIE Validation of the Korean Version of the Positive and Negative Sleep Appraisal Measure (PANSAM) as a Tool for Evaluating Dysfunctional Beliefs about Sleep among the General Population 2077-0383 2022-08-10
박덕우 SCIE Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial. 0009-7322 14.739 2022-08-09
안정민 SCIE Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial. 0009-7322 14.739 2022-08-09
양동현 SCIE Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial. 0009-7322 14.739 2022-08-09
박한빛 SCIE Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial. 0009-7322 39.922 2022-08-09
윤성철 SCIE Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial. 0009-7322 14.739 2022-08-09
이재홍 SCIE Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial. 0009-7322 14.739 2022-08-09
김경원 SCIE Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial. 0009-7322 14.739 2022-08-09
김대희 SCIE Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial. 0009-7322 14.739 2022-08-09
최성수 SCIE Prediction of Mortality after Burn Surgery in Critically Ill Burn Patients Using Machine Learning Models 2075-4426 2022-08-08
김동관 SCIE Long-term outcome of minimally invasive thymectomy versus open thymectomy for locally advanced cases 1010-7940 4.534 2022-08-03
안진희 SCIE Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma 1078-0432 13.801 2022-08-02
장세진 SCIE Data on the evaluation of the relation between β-arrestin 2 and YAP phosphorylation in patient-derived colon cancer organoids 2352-3409 2022-08-02
김송철 SCIE The impact of pylorus preservation on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy: A historical cohort study 1868-6974 3.149 2022-08-01